Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8241630 HER2 antibody composition

Patent 8241630 was granted and assigned to Genentech on August, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer

0

Edits on 9 Oct, 2024

"update inverses"

edited on 9 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof

0

Edits on 27 Jun, 2024

"update inverses"

edited on 27 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12018084 Anti-CXCR2 antibodies and uses thereof

0

Edits on 29 May, 2024

"update inverses"

edited on 29 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer

0

Edits on 15 May, 2024

"update inverses"

edited on 15 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11981744 Chimeric polypeptide assembly and methods of making and using the same

0

Edits on 29 Nov, 2023

"Add patent abstract"

edited on 29 Nov, 2023

Edits made to:

Article (+321 characters)

Article

Patent abstract

A composition comprising a main species HER2 antibody that binds to domain II of HER2, and an amino acid sequence variant thereof comprising an amino-terminal leader extension is disclosed. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.

Edits on 21 Sep, 2023

"Add patent inventor(s)"

edited on 21 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Martin Vanderlaan0

Yung-Hsiang Kao0

Edits on 2 Aug, 2023

"update inverses"

edited on 2 Aug, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11713358 Chimeric polypeptide assembly and methods of making and using the same

0

Edits on 24 May, 2023

"update inverses"

edited on 24 May, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11655305 Treatment of metastatic breast cancer

0

"update inverses"

edited on 24 May, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11654105 Subcutaneous HER2 antibody formulations

0

Edits on 23 May, 2023

"Remove leading 0 from patent number"

edited on 23 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 08241630 HER2 antibody composition US Patent 8241630 HER2 antibody composition

Infobox

Patent Number

082416300

Patent Number

82416300

Edits on 27 Sep, 2022

"Entity importer update"

edited on 27 Sep, 2022

Infobox

Is a

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

082416300

Date of Patent

August 14, 2012

0

Patent Application Number

129864700

Date Filed

January 7, 2011

0

Patent Primary Examiner

Laura B Goddard

0

Edits on 15 Dec, 2021

"Created via: Entity Importer"

created this topic on 15 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 08241630 HER2 antibody composition

Infobox

Is a

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

08241630

Date of patent

August 14, 2012

Patent application number

12986470

Date Filed

January 7, 2011

Patent primary examiner

Laura B Goddard

Find more entities like US Patent 8241630 HER2 antibody composition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool